Sign In

Alan Ezekowitz

Venture Partner at Third Rock Ventures

Dr. Alan Ezekowitz is a highly accomplished professional with a diverse background in biotechnology, venture capital, and academia. He holds a DPhil in Cell/Cellular and Molecular Biology from the University of Oxford, complemented by a medical degree from the University of Cape Town. Dr. Ezekowitz has held prominent roles in various organizations, including serving as an Advisory Partner and Venture Partner at Third Rock Ventures, Senior Consultant at Vividion Therapeutics. Inc., President and CEO at Abide Therapeutics, Principal at Alan Ezekowitz LLC, and SVP and Franchise Head at Merck Sharp & Dohme. With a strong foundation in pediatric care, he has also served as the Chief MassGeneral Hospital for Children at Mass General Hospital and as the Charles Wilder Professor of Pediatrics at Harvard Medical School, overseeing the Laboratory for Developmental Immunology at MGH.

Highlights

Mar 23 · linkedin

I’m proud to announce that I have joined the future Board of Directors of Organon, which will spin off from Merck & Co. in the first half of 2021. The vision of Organon is to be a leading global company dedicated to the health of women, and I am looking forward to helping lead this important work.

Alan Ezekowitz
Add to my network

Location

Princeton, New Jersey, United States